The US Department of Health and Human Services is demanding that pharmaceutical companies cut drug prices to the lowest price ...

By Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Cell division is an essential biological process that removes aged cells and continuously renews tissues. In the human body, billions of cells divide each day: intestinal cells are completely renewed ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...

Scientists have decoded the atomic structure of Photosystem I from a 3-billion-year-old cyanobacteria lineage, offering a unique look at early oxygen-producing photosynthesis. The ancient nanodevice, ...